Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Ibuprofen × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Pain 3 Cachexia 3 Breast Neoplasms 3 Trigger Finger Disorder 2 Prostatic Neoplasms 2 Lymphoma, Follicular 2 Lung Neoplasms 2 Inflammation 2 Ganglion Cysts 2 De Quervain Disease 2 Colorectal Neoplasms 2 Weight Loss 1 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Supratentorial Brain Tumor 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatitis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pleural Effusion, Malignant 1 Pituitary Neoplasms 1 Patient Satisfaction 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Nose Neoplasms 1 Neoplasm Metastasis 1 Mucositis 1 Menorrhagia 1

Interventions

Trastuzumab 7 Letrozole 7 Anastrozole 7 palbociclib 6 exemestane 6 Docetaxel 6 Fulvestrant 5 ribociclib 4 pyrotinib 4 entinostat 4 abemaciclib 4 Cyclophosphamide 4 Doxorubicin 3 pertuzumab 2 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Gonadotropin-Releasing Hormone 2 Exercise 2 Everolimus 2 Epirubicin 2 Drug Evaluation 2 Capecitabine 2 Botulinum Toxins, Type A 2 Blood Specimen Collection 2 Aromatase Inhibitors 2 AZD9833 2 tucatinib 1 trastuzumab deruxtecan 1 taxane 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00299039 2009-02-02

T3AI

Nova Scotia Health Authority

Phase 3 Completed

Agnosia, Breast Diseases, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡